Physician profile
Wayne C Sandler
NPI 1770549388
$1,918.81
in general payments reported to CMS, 2019-2025
8 companies · $537 in 2025
The $537 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.37 · 2020: $55.61 · 2021: $205 · 2022: $119 · 2023: $411 · 2024: $538 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,430 · Education: $55.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,430.29 |
| Education | $55.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $480.12 | 2021-2024 | Rexulti |
| Bausch Health US, LLC | $445.60 | 2023-2025 | Aplenzin, Wellbutrin |
| E.R. Squibb & Sons, L.L.C. | $341.65 | 2024-2025 | Cobenfy |
| Takeda Pharmaceuticals U.S.A., INC. | $195.54 | 2020-2024 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $166.61 | 2022-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $144.01 | 2025 | Caplyta |
| Axsome Therapeutics, INC. | $91.91 | 2025 | Auvelity |
| Shire North American Group INC | $53.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Sandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.